AMES + Brain Stimulation



Status:Active, not recruiting
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 75
Updated:12/9/2016
Start Date:July 2010
End Date:December 2019

Use our guide to learn which trials are right for you!

AMES + Brain Stimulation: Treatment for Profound Plegia in Stroke

The procedure involves: (1) assisted hand movement by a mechanical device, (2) mechanical
vibration applied to the surface of the forearm, and (3) stimulation of the brain with
either transcranial magnetic stimulation (TMS) or transcortical direct current stimulation
(DCS). These 3 components of the procedure are carried out simultaneously. Each subject will
be evaluated pre- and post-treatment with several clinical tests of functional movement. The
hypotheses of this project are that the AMES+rTMS and AMES+tDCS procedures are safe and will
enable most of the stroke patients to recover finger extension.

This protocol is designed to investigate the safety and efficacy of a procedure for treating
chronic (>1 year post) stroke patients who still cannot move the hand affected by the
stroke. The treatment involves: (1) assisted hand movement by a mechanical device, (2)
mechanical vibration applied to the surface of the forearm, and (3) stimulation of the brain
with either transcranial magnetic stimulation (TMS) or transcortical direct current
stimulation (DCS). Subjects receiving TMS during treatment are expected to respond more
fully (i.e., increased volitional EMG) in the treated hand compared to those receiving DCS.

Inclusion Criteria:

- Stroke occurring ≥12 months before enrollment

- Hemispheric stroke (ischemic or hemorrhagic), cortical or subcortical

- Residual upper-extremity weakness without the ability to activate volitionally
extensor digitorum (no volitional EMG in the long finger extensor
muscle)independently

- Age 18-75 years old

Exclusion Criteria:

- Significant upper-extremity proprioceptive deficit (<70% correct detection of the
direction of passive finger movement, with eyes closed)

- Cortical stroke involving the primary motor cortex

- Epilepsy not controlled by medication

- Botox injections 5 months before or during enrollment; use of intrathecal Baclofen

- Residual pain in the tested arm

- Significant neglect involving the affected limb (NIHSS 2 on the extinction and
attention items)

- Exercise intolerant

- Uncontrolled hypertension or angina

- Cognitive or behavioral inability to follow instructions

- Current abuse of alcohol or drugs

- Terminal illness with anticipated survival of <12 months

- Severe apraxia; inability to understand oral directions in English; or inability to
communicate adequately with study personnel

- Circumference of arm incompatible with the AMES device (checked by placing the limb
in the device)

- Contractures, decreased range of motion, or skin condition preventing tolerance of
the AMES muscle vibrators

- Spinal cord injury, arthritis, or fractures of affected limbs resulting in loss of
range of motion

- In the tested arm, peripheral nerve injury or neuropathy resulting in significant
motor or sensory loss

- Pathological neurological/physical condition other than stroke that impairs the
function of the impaired arm or that produces pain in the impaired arm

- Implanted device (e.g., cardiac pacemaker, Baclofen pump) the operation of which
might be adversely affected by the brain stimulation

- Previous vascular surgery on the blood vessels of the brain or heart or heart valve
surgery

- Female and pregnant
We found this trial at
1
site
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials